Hiroaki Ono

Years Active: 2021-2022
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Takeshi Ishii, Yoshimitsu Akiyama, Shu Shimada, Ayano Kabashima, Daisuke Asano, Shuichi Watanabe, Yoshiya Ishikawa, Hiroki Ueda, Keiichi Akahoshi, Kosuke Ogawa, Hiroaki Ono, Atsushi Kudo, Minoru Tanabe, Shinji Tanaka
Identification of a novel target of SETD1A histone methyltransferase and the clinical significance in pancreatic cancer. Cancer science (2022)
Yoshiki Murase, Hiroaki Ono, Kosuke Ogawa, Risa Yoshioka, Yoshiya Ishikawa, Hiroki Ueda, Keiichi Akahoshi, Daisuke Ban, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe
Inhibitor library screening identifies ispinesib as a new potential chemotherapeutic agent for pancreatic cancers. Cancer science 112 (11) (2021)
Tomotaka Kato, Hiroaki Ono, Mikiya Fujii, Keiichi Akahoshi, Toshiro Ogura, Kosuke Ogawa, Daisuke Ban, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe
Cytoplasmic RRM1 activation as an acute response to gemcitabine treatment is involved in drug resistance of pancreatic cancer cells. PloS one 16 (6) (2021)
Toshitaka Sugawara, Daisuke Ban, Jo Nishino, Shuichi Watanabe, Aya Maekawa, Yoshiya Ishikawa, Keiichi Akahoshi, Kosuke Ogawa, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe
Prediction of early recurrence of pancreatic ductal adenocarcinoma after resection. PloS one 16 (4) (2021)

Hiroaki Ono.css-eqlu8i{font-size:small;padding-left:4px;}